Cortico-retinal decoupling in anisometropic amblyopia: OCTA-VEP multimodal biomarkers reveal neurovascular mismatch patterns Authors: Xindan Meng, Qing Wang, Yixia Zhang Published: 2026 ABSTRACT AbstractBackgroundTo investigate the retinal microcirculation changes in children with anisometropic amblyopia through multimodal assessment and explore its correlation with neurophysiological dysfunction.MethodsThis prospective cross-sectional study recruited 68 treatment-naïve children (aged 4–14 years) with primary monocular anisometropic amblyopia. The fellow healthy eye served as the control. Macular microvascular parameters, including foveal avascular zone (FAZ) area and superficial capillary plexus (SCP) perfusion density, were quantified using optical coherence tomography angiography (OCTA). Pattern visual evoked potentials (P-VEP) assessed P100 latency and amplitude. Central macular thickness (CMT) and retinal nerve fiber layer (RNFL) thickness were measured. Correlations and multiple linear regression analyses were performed to identify predictors of best-corrected visual acuity (BCVA) in amblyopic eyes.ResultsCompared to fellow eyes, amblyopic eyes exhibited significant microcirculatory impairment: reduced SCP perfusion density (central: 0.27 vs. 0.29, P < 0.001; full: 0.44 vs. 0.46, P < 0.05), enlarged FAZ area (0.30 vs. 0.26 mm², P = 0.035), and increased CMT (141.00 vs. 131.50 μm, P < 0.05) and RNFL thickness (113.00 vs. 110.00 μm, P < 0.001). P-VEP revealed prolonged P100 latency (119.0 vs. 109.5 ms, P < 0.001) and decreased amplitude (12.8 vs. 19.25 µV, P < 0.001). SCP perfusion density correlated negatively with P100 latency (ρ=-0.341, P = 0.004), and SCP vessel density correlated negatively with CMT (ρ=-0.363, P = 0.002) and FAZ area (ρ=-0.424, P < 0.001). Multiple linear regression analysis (adjusted R²=0.625, P < 0.001) identified RNFL thickness (β = -0.546, P < 0.001) as a significant negative predictor of BCVA (logMAR), while SCP full perfusion density (β = 0.375, P < 0.001) and axial length (β = 0.237, P = 0.007) were significant positive predictors.ConclusionAnisometropic amblyopia is marked by a neurovascular mismatch, manifested through simultaneous retinal hypoperfusion, paradoxical thickening of structures, and delayed neural conduction. The combined OCTA-P-VEP assessment provides a comprehensive biomarker framework. RNFL thickness, SCP perfusion density, and axial length emerge as key independent predictors of visual acuity, suggesting complex interplays between structure, perfusion, and function.Keywords: Anisometropic amblyopia, Optical coherence tomography angiography (OCTA), Pattern visual evoked potential (P-VEP), Neurovascular coupling, Retinal microcirculation Introduction Amblyopia is a neurodevelopmental disorder characterized by reduced visual acuity in one or both eyes, resulting from various abnormalities that occur during the critical period of visual system development.These abnormalities encompass monocular strabismus, uncorrected anisometropia, significant refractive errors, and form deprivation. It stands for one of the most widespread visual impairments among children1, with a global incidence of roughly 2% to 4% [1].Notably, anisometropic amblyopia—a subtype characterized by a spherical equivalent difference of ≥ 1.5D or a cylindrical difference of ≥1D between the two eyes—holds significant clinical importance among such conditions.The exact etiology of amblyopia remains unclear, particularly regarding the interplay between hereditary and environmental factors. However, abnormalities in the retina-geniculate-striate pathway are recognized as the primary neural basis of amblyopia, with retinal-level alterations identified as a key contributor to amblyopic deficits [2–4]. Early diagnosis and intervention are crucial, as studies indicate that if left untreated before the age of 6 (i.e. before the end of the critical period of cortical plasticity), approximately 3.6% of untreated cases may develop irreversible vision loss [5]. Without timely screening and treatment, amblyopia can lead to permanent visual impairment or dysfunction in children, significantly impacting their developmental trajectory and quality of life. As medical imaging technology continues to advance, OCTA has become an essential tool in clinical practice for the noninvasive observation of retinal microvasculature [6].OCTA provides three-dimensional, high-resolution images of blood flow [7], allowing for the quantitative assessment of blood flow density in both the SCP/DCP [8], and precise measurement of the FAZ area. This enhances its diagnostic value in evaluating retinal structures [9], while also avoiding the potential adverse reactions associated with traditional angiography [10]. Additionally, OCTA offers critical insights into retinal hemodynamics, broadening its applications in ophthalmology [11, 12]. Concurrently, P-VEP serves as an alternative approach to evaluate visual function, objectively reflecting the functionality of ganglion cells and the completeness of the visual pathway [13]. Currently, numerous clinical studies have focused intently on exploring the morphological alterations within the retinas of amblyopic patients. A burgeoning body of OCTA literature has further documented significant changes in retinal vessel density among amblyopic eyes [14–16]. Similarly, P-VEP studies consistently reveal prolonged latency and diminished amplitude in amblyopia [17]. However, the vast majority of research has scrutinized these distinct modalities—OCTA-derived vascular metrics, OCT-based structural parameters, and VEP functional measures—independently. Research has shown a significant synergistic effect between OCTA structural data and P-VEP functional measurements [18], which is particularly important for studies on neurodegenerative ocular diseases. Nevertheless, comprehensive research on the correlation between microvascular parameters and electrophysiological responses is still insufficient, particularly in the field of developmental visual disorders. This highlights the urgent need for a multimodal evaluation system that integrates advanced imaging and functional testing technologies. This study aims to address this gap by employing a multimodal approach. We investigate retinal microvascular alterations using OCTA, correlate them with structural parameters (CMT, RNFL), and integrate these findings with functional assessments via P-VEP in children with anisometropic amblyopia. We hypothesize that a disruption in the normal neurovascular relationship—a “mismatch” between perfusion, structure, and function—underlies the pathophysiology. This study seeks to provide a cohesive biomarker profile for early detection, mechanistic insight, and potentially novel therapeutic targets. Research object and method Study design and participants This was a prospective, cross-sectional, observational study. Prospectively included were 68 patients with monocular anisometropic amblyopia who received initial treatment at Chongqing Aier Eye Hospital and Chongqing Nanping Aier Eye Hospital between November 2022 and December 2024, aged between 4 and 14 years, using the contralateral healthy eye as the control group. Diagnostic and inclusion criteria Confirmed diagnosis of anisometropic amblyopia based on clinical manifestations and cycloplegic refraction results. Confirmed diagnosis of anisometropic amblyopia based on clinical manifestations and cycloplegic refraction results. Unilateral amblyopia with normal visual acuity in the contralateral eye. BCVA thresholds were defined as follows in logMAR notation : Age 4–5 years: BCVA > 0.22 logMAR (Snellen equivalent < 6/9.5 or decimal < 0.6).Age 6–7 years: BCVA > 0.15 logMAR (Snellen equivalent < 6/8.5 or decimal < 0.7).Age 8–14 years: BCVA > 0.10 logMAR (Snellen equivalent < 6/7.5 or decimal < 0.8). Interocular BCVA difference ≥ 2 lines. Unilateral amblyopia with normal visual acuity in the contralateral eye. BCVA thresholds were defined as follows in logMAR notation : Age 4–5 years: BCVA > 0.22 logMAR (Snellen equivalent < 6/9.5 or decimal < 0.6).Age 6–7 years: BCVA > 0.15 logMAR (Snellen equivalent < 6/8.5 or decimal < 0.7).Age 8–14 years: BCVA > 0.10 logMAR (Snellen equivalent < 6/7.5 or decimal < 0.8). Age 4–5 years: BCVA > 0.22 logMAR (Snellen equivalent < 6/9.5 or decimal < 0.6). Age 4–5 years: BCVA > 0.22 logMAR (Snellen equivalent < 6/9.5 or decimal < 0.6). Age 6–7 years: BCVA > 0.15 logMAR (Snellen equivalent < 6/8.5 or decimal < 0.7). Age 6–7 years: BCVA > 0.15 logMAR (Snellen equivalent < 6/8.5 or decimal < 0.7). Age 8–14 years: BCVA > 0.10 logMAR (Snellen equivalent < 6/7.5 or decimal < 0.8). Age 8–14 years: BCVA > 0.10 logMAR (Snellen equivalent < 6/7.5 or decimal < 0.8). Interocular BCVA difference ≥ 2 lines. No history of amblyopia treatment (e.g.,occlusion therapy, pharmacologic penalization) within the preceding 3 months. No history of amblyopia treatment (e.g.,occlusion therapy, pharmacologic penalization) within the preceding 3 months. Absence of ocular organic lesions or systemic comorbidities. Absence of ocular organic lesions or systemic comorbidities. Exclusion criteria Diagnosis of refractive amblyopia or sensory deprivation amblyopia. Diagnosis of refractive amblyopia or sensory deprivation amblyopia. History of glaucoma, cataracts, retinal pathologies, strabismus, nystagmus, or oculomotor disorders. History of glaucoma, cataracts, retinal pathologies, strabismus, nystagmus, or oculomotor disorders. Prior intraocular surgery or conditions affecting microvascular hemodynamics (e.g., diabetes, hypertension). Prior intraocular surgery or conditions affecting microvascular hemodynamics (e.g., diabetes, hypertension). Contraindications to examinations: inability to maintain fixation, media opacities precluding quality imaging, known hypersensitivity to mydriatic agents). Contraindications to examinations: inability to maintain fixation, media opacities precluding quality imaging, known hypersensitivity to mydriatic agents). Inability to cooperate with study protocols or systemic organic diseases. Inability to cooperate with study protocols or systemic organic diseases. Ethical compliance The study was approved by the Ethics Review Committee of Chongqing Nanping Aier Eye Hospital Group (Approval No: IRB-2022-001) in accordance with the Declaration of Helsinki. Written informed consent was obtained from a legally authorized guardian after explanation of risks and benefits. Methods Routine ophthalmic examination Ophthalmologists measured the BCVA( converted to logMAR scale) of all subjects using the international standard visual acuity chart. Using a slit-lamp biomicroscope, the anterior segment and fundus were examined, axial length (AL) was measured using the German Zeiss IOLMaster 500, and refraction was performed after pupil dilation with compound tropicamide eye drops. Routine examinations also included fundus photography, ocular alignment assessment, and evaluation of ocular motility. VEP testing Testing was conducted using the Roland electrophysiological diagnostic system GANZFELD Q450. According to the International Society for Clinical Electrophysiology of Vision(ISCEV) extended protocol [19], parameters of the P-VEP P100 wave were recorded, including the latency (ms) and amplitude (uV) of the P100 wave at 1.0 deg (60 checks) and 15 min. OCTA examination OCTA was acquired by certified technicians using the CIRRUS HD-OCT 5000 (software version 11.0, Carl Zeiss Meditec, Inc.) in accordance with imaging guidelines [20]. Macular Structure: CMT was measured via the macular cube 512 × 128 scan protocol, with results interpreted within the 1 mm CMT (measurement range: inner limiting membrane to retinal pigment epithelium). Peripapillary RNFL: Using the 200 × 200 optic disc cube protocol, the average thickness of the RNFL was determined, a 3.4 mm diameter circular scan was performed, and the RNFL average thickness was calculated from the images. Macular Microvasculature: A 6 × 6 mm macular scan was analyzed using the FORUM software. The macular center was divided into three concentric circles: the central zone (1 mm diameter), inner ring (3 mm diameter), and outer ring (6 mm diameter). Parameters included: SCP Perfusion Density: The proportion of the total area occupied by perfused vasculature in the SCP layer. SCP Perfusion Density: The proportion of the total area occupied by perfused vasculature in the SCP layer. SCP Vessel Density: The total length of skeletonized vessels per unit area (mm- 1) in the SCP. SCP Vessel Density: The total length of skeletonized vessels per unit area (mm- 1) in the SCP. FAZ Metrics: Area (mm²), perimeter, and circularity index (Fig. 1a and b). (Note:①The inner boundary of the SCP image scanning range is 3 μm beneath the inner limiting membrane, and the outer boundary is 15 μm under the inner plexiform layer [11]. ②Axial Length and Magnification: We acknowledge that significant interocular AL differences (see Results) can induce magnification artifacts in OCTA measurements. While individualized lateral scaling correction (e.g., Bennett’s formula) is ideal, retrospective application was not feasible with our dataset. This potential confounder is explicitly addressed in the Limitations section. FAZ Metrics: Area (mm²), perimeter, and circularity index (Fig. 1a and b). (Note:①The inner boundary of the SCP image scanning range is 3 μm beneath the inner limiting membrane, and the outer boundary is 15 μm under the inner plexiform layer [11]. ②Axial Length and Magnification: We acknowledge that significant interocular AL differences (see Results) can induce magnification artifacts in OCTA measurements. While individualized lateral scaling correction (e.g., Bennett’s formula) is ideal, retrospective application was not feasible with our dataset. This potential confounder is explicitly addressed in the Limitations section. a. FAZ (yellow - automatically identified). b. FAZ (yellow - manually drawn). Note: Foveal avascular zone (FAZ): After selection, it is highlighted in yellow, and the FAZ area, perimeter, and morphological indices are calculated Data collection and blinding Professional technicians, who were masked to the amblyopia status of each eye, were responsible for collecting inspection data, which includes retinal structural parameters, P100 wave latency, and amplitude of P-VEP, as well as recording the basic information of children, such as age, gender, and anisometropia. Observation indicators The primary comparisons were cross-sectional between the amblyopic eye and the fellow eye at baseline: Basic clinical parameters: BCVA, AL, refractive error.P-VEP parameters: P100 latency and amplitude.OCTA parameters: SCP perfusion density, SCP vessel density, FAZ area.Structural parameters: CMT and RNFL thickness. The primary comparisons were cross-sectional between the amblyopic eye and the fellow eye at baseline: Basic clinical parameters: BCVA, AL, refractive error.P-VEP parameters: P100 latency and amplitude.OCTA parameters: SCP perfusion density, SCP vessel density, FAZ area.Structural parameters: CMT and RNFL thickness. Basic clinical parameters: BCVA, AL, refractive error. Basic clinical parameters: BCVA, AL, refractive error. P-VEP parameters: P100 latency and amplitude. P-VEP parameters: P100 latency and amplitude. OCTA parameters: SCP perfusion density, SCP vessel density, FAZ area. OCTA parameters: SCP perfusion density, SCP vessel density, FAZ area. Structural parameters: CMT and RNFL thickness. Structural parameters: CMT and RNFL thickness. Secondary analysis involved correlation analysis among these variables within amblyopic and fellow eyes. Secondary analysis involved correlation analysis among these variables within amblyopic and fellow eyes. Statistical methods SPSS 26 software was utilized for statistical analysis. The Shapiro - Wilk test was used to assess normality of continuous variables. Normally distributed continuous variables are presented as mean ± standard deviation (SD); non-normally distributed variables as median and interquartile range [IQR] and analyzed with the Mann-Whitney U test. Correlations used Spearman’s rank coefficient (ρ).A multiple linear regression model (enter method) was constructed with BCVA (logMAR) of the amblyopic eye as the dependent variable. Independent variables included: RNFL thickness, SCP full perfusion density, axial length, P100 latency at 1.0°, FAZ area, and CMT. Collinearity diagnostics (variance inflation factor, VIF) and residual analysis were performed to validate model assumptions. Significance was set at α = 0.05. Result Comparison of basic clinical data This observational study evaluated 68 children who met the ICD-11 criteria, with similar distributions in age, gender, and eye (Table 1). No statistically significant differences were observed in age distribution between groups. Visual function was quantified using ISO-certified logarithmic visual acuity charts and a MATLAB-based algorithmic system, with best-corrected visual acuity transformed into LogMAR scale values. Non-quantifiable responses were digitally processed using a clinical-grade conversion matrix (FC = 2.6, HM = 2.7, LP = 2.8, NLP = 2.9) [13]. Table 1Subject basic informationCategoryDataNumber of patients (individuals, with/without amblyopia)68(68/68)Age (years, mean ± standard deviation)8.54 + 2.76Gender (Male/Female)35(51.5%)/33༈48.5%༉Eye(Right/Left)31(45.6%)/37(54.4%)Note: n, number; SD, standard deviation Subject basic information Note: n, number; SD, standard deviation Table 2 indicates that the baseline data of patients with anisometropic amblyopia exhibit significant disparities in BCVA and AL between amblyopic and normal eyes. This is characterized by a tendency towards hyperopic anisometropia, as evidenced by non-cycloplegic refraction (Z=-6.848, P < 0.05) and cycloplegic refraction (Z=-6.84, P < 0.05). Additionally, the AL of amblyopic eyes was found to be shorter, with statistically significant differences (Z=-4.293, P < 0.05). Table 2Baseline clinical characteristics of amblyopic and fellow eyesParameterUCVA (logMAR)BCVA (logMAR)AL (mm)Refraction (Non-cyclo., D)Refraction (Cyclo., D)Amblyopic EyesM[IQR]0.70[0.52,0.79]0.40[0.30,0.40]21.03[20.16,22.43]+ 3.25[2.00,3.75]+ 3.00[+ 2.00,+3.75]Fellow EyesM[IQR]0.10[0,0.10]0[0,0.10]23.47[23.00,23.54]+ 0.125[-0.50,0.75]+ 0.125[-0.50,0.75]Z-value-7.135-7.261-4.293-6.848-6.84P-value< 0.001< 0.001< 0.001< 0.001<0.001Note: ① UCVA, uncorrected visual acuity; BCVA, best-corrected visual acuity; AL, axial length; M, median; IQR, interquartile range; D, diopters; Non-cyclo., non-cycloplegic; Cyclo., cycloplegic. All visual acuities in logMAR. Statistical test: Mann-Whitney U test. ② Amblyopic eyes had significantly worse BCVA, shorter AL, and greater hyperopic refractive error compared to fellow eyes (P < 0.001), consistent with hyperopic anisometropia Baseline clinical characteristics of amblyopic and fellow eyes Amblyopic Eyes M[IQR] Fellow Eyes M[IQR] Note: ① UCVA, uncorrected visual acuity; BCVA, best-corrected visual acuity; AL, axial length; M, median; IQR, interquartile range; D, diopters; Non-cyclo., non-cycloplegic; Cyclo., cycloplegic. All visual acuities in logMAR. Statistical test: Mann-Whitney U test. ② Amblyopic eyes had significantly worse BCVA, shorter AL, and greater hyperopic refractive error compared to fellow eyes (P < 0.001), consistent with hyperopic anisometropia Comparison of P-VEP results As indicated in Table 3, amblyopic eyes demonstrated a significantly prolonged P100 wave latency at 1.0° (Z1.0 deg=-6.870, P < 0.05), whereas the latency difference at 15’ was not significant (Z15min=-1.855, P = 0.064 > 0.05). This implies that the duration from the central image entering the eye at 1.0° to the generation of the retinal neuron action potential (electrical signal) is extended, although the observable response time difference from stimulus onset is not significant. Nonetheless, the overall results suggest delayed retinal evoked potentials. Furthermore, the P100 wave amplitude in amblyopic eyes was markedly diminished compared to normal eyes (Z1.0 deg=-6.157, Z15min=-6.417, P < 0.05). Table 3Comparison of P100 latency and amplitudeParameterVEP (P100 wave)[M(P25,P75)]1.0° Latency (ms)1.0° Amplitude (µV)15’ Latency (ms)15’ Amplitude (µV)Amblyopic EyesM[IQR]119.0 [117.0, 121.0]12.8 [12.43, 14.9]114.5 [111.0, 117.0]8.11 [5.69, 9.38]Fellow Eyes M[IQR]109.5 [108.0, 114.0]19.25 [18.10, 21.10]114.0 [109.0, 117.0]12.40 [10.50, 13.10]Z-value-6.870-6.157-1.855-6.417P-value< 0.001< 0.0010.064< 0.001Note: ①P-VEP, pattern visual evoked potential; M, median; IQR, interquartile range; ms, milliseconds; µV, microvolts. Statistical test: Mann-Whitney U test Comparison of P100 latency and amplitude Amblyopic Eyes M[IQR] Note: ①P-VEP, pattern visual evoked potential; M, median; IQR, interquartile range; ms, milliseconds; µV, microvolts. Statistical test: Mann-Whitney U test Quantitative parameters of retinal blood flow, area of foveal avascular zone (FAZ), thickness of ganglion cell fiber layer (NFL), and results of central macular thickness (CMT) Table 4 indicates that, compared with fellow eyes, amblyopic eyes demonstrated significant differences in the blood flow density of the SCP within the macular region, specifically at the fovea and inner ring areas (ZCen=-7.129, ZIn=-6.023, P < 0.05). However, no noticeable difference was found in the outer ring (Zout=-1.797, P = 0.072 > 0.05). The overall retinal blood flow in the 6*6 mm macular region was notably reduced (ZFull=-3.906, P < 0.05). Furthermore, the microvascular density of the SCP in the macular region of amblyopic eyes was significantly lower than that in fellow eyes (ZCen=-6.951, ZIn=-6.488, Zout=-3.172, ZFull=-4.756, P < 0.05). Table 4Comparison of retinal perfusion and vessel densityParameterSCP Perfusion DensityCentralInnerOuterFullAmblyopic EyesM [IQR]0.27 [0.10, 0.22]0.39 [0.35,0.42]0.47 [0.38,0.47]0.44 [0.38,0.45]Fellow EyesM [IQR]0.29 [0.23, 0.35]0.43 [0.39,0.46]0.47 [0.39,0.47]0.46 [0.39,0.47]Z-value-7.129-6.023-1.797-3.906P-value< 0.001< 0.0010.072< 0.001ParameterSCP Vessel Density (mm-¹) Central Inner Outer Full Amblyopic EyesM [IQR]9.40 [4.95,9.70]16.20 [13.73,17.10]18.30 [15.60,18.60]17.60 [14.80,18.20]Fellow EyesM [IQR]12.70 [10.50,14.50]18.45 [15.80,18.70]18.60 [16.10,18.88]18.30 [16.70,18.60]Z-value-6.951-6.488-3.172-4.756P-value< 0.001< 0.0010.002< 0.001Note: OCTA, optical coherence tomography angiography; SCP, superficial capillary plexus; M, median; IQR, interquartile range. Perfusion density is unitless ratio; vessel density in mm-¹. Statistical test: Mann-Whitney U test Comparison of retinal perfusion and vessel density Amblyopic Eyes M [IQR] Fellow Eyes M [IQR] Amblyopic Eyes M [IQR] Fellow Eyes M [IQR] Note: OCTA, optical coherence tomography angiography; SCP, superficial capillary plexus; M, median; IQR, interquartile range. Perfusion density is unitless ratio; vessel density in mm-¹. Statistical test: Mann-Whitney U test Table 5 indicates that, Amblyopic eyes enlarged FAZ, and increased CMT and RNFL thickness compared to fellow eyes. (ZFAZ=-2.106, P = 0.035 < 0.05, ZCMT=-3.967, P < 0.05; ZNFL=-5.118, P < 0.05). Table 5Comparison of FAZ, CMT, and RNFL thicknessParameterFAZCMT (µm)RNFL Thickness (µm)Area (mm²)Perimeter (mm)Morph IndexAmblyopic EyesM [IQR]0.30[0.16,0.34]2.20[1.85,2.46]0.68[0.63,0.81]141.00[135.00,147.00]113.00[110.00,116.00]Fellow EyesM [IQR]0.26[0.19,0.42]1.99[1.97,3.65]0.59[0.41,0.76]131.50[127.25,142.75]110.00[108.00,112.00]Z-value-2.106-3.595-4.142-3.967-5.118P-value0.035< 0.001< 0.001< 0.001< 0.001Note: FAZ, foveal avascular zone; CMT, central macular thickness; RNFL, retinal nerve fiber layer; M, median; IQR, interquartile range; µm, micrometers. Statistical test: Mann-Whitney U test Comparison of FAZ, CMT, and RNFL thickness Amblyopic Eyes M [IQR] Fellow Eyes M [IQR] Note: FAZ, foveal avascular zone; CMT, central macular thickness; RNFL, retinal nerve fiber layer; M, median; IQR, interquartile range; µm, micrometers. Statistical test: Mann-Whitney U test Analysis of correlation between indicators Table 6 results indicate: (1) In amblyopic eyes, lower SCP vessel density correlated with larger FAZ area (r=-0.424, p = 0.000) and thicker CMT (r=-0.363, p = 0.002). (2) In amblyopic eyes, SCP vessel and blood flow density are negatively correlated with P100 wave latency (1.0 deg-latency) (r=-0.366, r=-0.341, p < 0.02), implying that higher SCP vessel density in the macular region corresponds to shorter P100 latency; in both amblyopic and fellow eyes, SCP vessel density in the macular region shows a significant negative correlation with P100 amplitude values (15 min-amplitude) (p < 0.05). Table 6Correlation of macular microvascular density with other parametersParameterCMTRNFLSCP Vessel DensitySCP Perfusion DensityFAZ AreaP100 LatencyCMT10.393*-0.363*0.0460.442*0.185RNFL1-0.217-0.255*0.552*0.056SCP Vessel Density10.627*-0.424*-0.366*SCP Perfusion Density1-0.340*-0.341*FAZ Area10.103P100 Latency1Note: *P < 0.05. CMT, central macular thickness; RNFL, retinal nerve fiber layer; SCP, superficial capillary plexus; FAZ, foveal avascular zone Correlation of macular microvascular density with other parameters Note: *P < 0.05. CMT, central macular thickness; RNFL, retinal nerve fiber layer; SCP, superficial capillary plexus; FAZ, foveal avascular zone Regression analysis: predictors of BCVA in amblyopic eyes A multiple linear regression was performed to identify independent predictors of BCVA (logMAR) in amblyopic eyes. The overall model was statistically significant (F(6,61) = 17.087, P < 0.001) and explained a substantial proportion of variance in visual acuity (adjusted R² = 0.625). As shown in Table 7, three variables emerged as significant independent predictors. RNFL thickness demonstrated a strong negative association with BCVA (β = -0.546, P < 0.001), indicating that greater RNFL thickness was associated with better visual acuity (lower logMAR). In contrast, SCP full perfusion density (β = 0.375, P < 0.001) and axial length (β = 0.237, P = 0.007) showed significant positive associations with BCVA, meaning that higher perfusion density and longer axial length were paradoxically associated with worse visual acuity (higher logMAR) after accounting for other factors. P100 latency, P100 amplitude, FAZ area, and CMT did not contribute significantly to the model (all P > 0.05). Collinearity diagnostics revealed no serious multicollinearity (all VIF < 2), and residual analysis supported the model assumptions (normality and homoscedasticity of residuals). Table 7Linear regression model for predicting BCVA in amblyopic eyesPredictor VariableUnstandardized βStandardized β (Beta)t-valueP-valueVIF(Constant)1.262-3.996< 0.001-RNFL Thickness (µm)-0.01-0.546-5.254< 0.0011.769SCP Perfusion Density0.0190.3754.051< 0.0011,402Axial Length (mm)0.0120.2372.7870.0071.177P100 Latency (1.0°) (ms)-0.002-0.131-1.5450.1271.176FAZ Area (mm²)0.0930.1411.2810.2051.992CMT (µm)-0.001-0.088-0.890.3771.613Note: Dependent Variable: BCVA (logMAR) of the amblyopic eye. Adjusted R²=0.625,F(6,61) = 17.087, p < 0.001 Linear regression model for predicting BCVA in amblyopic eyes Note: Dependent Variable: BCVA (logMAR) of the amblyopic eye. Adjusted R²=0.625,F(6,61) = 17.087, p < 0.001 Discussion This study systematically investigates the causes and clinical significance of retinal microvascular changes in patients with anisometropic amblyopia using multimodal imaging techniques.This study demonstrates a distinct neurovascular mismatch in anisometropic amblyopia, characterized by concurrent retinal hypoperfusion, structural thickening (CMT/RNFL), and impaired visual pathway conduction (prolonged VEP latency). This pattern suggests a decoupling between vascular supply, structural integrity, and neural function. This study deepens the understanding of anisometropic amblyopia, addresses key issues regarding retinal microvascular alterations, and offers insights for improving treatment efficacy, thereby laying a foundation for subsequent research.Future research will focus on the long-term relationship between microvascular changes and visual prognosis, as well as exploring therapeutic strategies. The amplitude of the P100 wave in amblyopic eyes was found to be reduced and the latency prolonged, indicating significant differences compared to healthy eyes (P < 0.05). This is consistent with the findings of most scholars [21]. The pathophysiological mechanism of anisometropic amblyopia originates from significant anisometropia, causing asymmetric resolution of retinal imaging between the two eyes, disrupting the neural synchronization of retinal-cortical signal transmission, and manifesting as functional decoupling between retinal input processing and cortical integration mechanisms. Neurophysiological studies also suggest temporal delays in signal integration along the amblyopic pathway during cortical processing [22, 23], leading to prolonged P100 wave latency. On the other hand, the onset of amblyopia can impair synaptic plasticity in visual cortical pyramidal neurons, resulting in phenomena such as neuronal loss and dysfunction [24]. In the present study, reduced macular perfusion density exhibited a correlation with prolonged P100 latency. This observation implies a potential linkage between retinal hemodynamic disturbances and delayed visual signal transmission. Nevertheless, it remains uncertain whether microcirculatory impairment directly contributes to the electrophysiological delay, or if both phenomena stem from a shared upstream disruption in visual development. Consistent with prior research, we observed markedly reduced blood flow density and vascular density in the macular region of amblyopic eyes compared to fellow eyes. This microcirculatory deficit likely stems from dysregulation of key vasoactive factors—notably decreased nitric oxide (NO) and elevated endothelin-1 (ET-1)—triggered by imbalanced visual input, compounded by dysfunction in retinal glial cells (e.g.Müller cells) essential for maintaining vascular homeostasis [25–29]. The macular region’s high metabolic demand renders it vulnerable to hypoperfusion. Our findings demonstrate an association between anisometropic amblyopia and retinal microcirculatory differences, suggesting that vascular impairment may accompany neurodevelopmental abnormalities in this condition. Notably, while group-level comparisons demonstrated reduced perfusion in amblyopic eyes, the regression analysis revealed a positive relationship between SCP perfusion density and BCVA logMAR (β = 0.375, P < 0.001) within the amblyopic group, meaning that higher perfusion density correlated with worse visual acuity. This unexpected finding may reflect a compensatory vascular response to heightened metabolic demand in more severely affected eyes, or “inefficient perfusion” stemming from underlying neurovascular uncoupling. However, this interpretation remains speculative and requires verification through longitudinal studies. We observed significant enlargement of the FAZ area alongside increased CMT and RNFL thickness in amblyopic eyes compared to fellow eyes, consistent with previous studies [30, 31]. These findings—microvascular dropout coexisting with structural thickening—have been hypothesized to reflect an “early thickening” response. The pathophysiological mechanism may involve compensatory responses to retinal ischemia, where retinal tissue upregulates HIF-1α under hypoxic stress, inducing the overexpression of downstream mediators such as VEGF and activating the Nuclear Factor Kappa-Light-Chain-Enhancer of Activated B Cells (NF-κB) and Mitogen-Activated Protein Kinase (MAPK) signaling pathways. This leads to increased expression of inflammatory cytokines and adhesion molecules [32, 33]. These adaptive changes manifest acutely as heightened vascular permeability, plasma extravasation, and retinal thickening. However, we observed no progressive RNFL thinning with increasing age within our cohort. This lack of an age-dependent thinning pattern indicates that the “early thickening, late atrophy” hypothesis cannot be substantiated by our cross-sectional data and necessitates prospective longitudinal validation. The research shows that in the macular region of amblyopic eyes, there is a negative correlation between the vascular density of the SCP and the FAZ. The expansion of the FAZ mirrors the extent of macular ischemia and hypoxia, serving as an indicator to assess the severity of amblyopia. A larger FAZ area generally suggests more severe retinal microcirculation impairment and potentially greater visual function damage. However, our regression analysis demonstrated that RNFL thickness independently predicted superior visual acuity (β = -0.581, P < 0.001) within the amblyopic group, suggesting that structural preservation of the nerve fibre layer is associated with better functional outcomes. Conversely, FAZ area and CMT failed to retain independent predictive value in the multivariate model, indicating their effects on visual outcome may be mediated through other factors. This study uncovered significant correlations between retinal microvascular parameters, structural measures, and visual function in anisometropic amblyopia. These findings shed light on the underlying pathophysiology of this condition. However, whether incorporating microvascular analysis into routine clinical examination improves diagnostic accuracy or guides personalized treatment remains uncertain from these cross-sectional data and necessitates dedicated, prospective clinical utility studies. The observed relationship between macular perfusion and visual acuity strongly indicates that longitudinal assessment of perfusion changes during treatment could offer valuable insights into therapeutic response. Future research ought to investigate whether alterations in retinal microcirculation correlate with functional improvement following amblyopia therapy. Furthermore, studies exploring the pivotal role of glial cells in retinal vascular regulation may unveil novel therapeutic approaches. Methodological considerations and limitations We acknowledge several important limitations. First, our cross-sectional design precludes establishing causal relationships. Second, while the significant axial length difference between amblyopic and fellow eyes represents a core feature of hyperopic anisometropia, it introduces a potential confounding factor for OCTA measurements through magnification effects. The absence of prospective optical correction constitutes a further study limitation; future investigations should incorporate axial length-adjusted scaling.Third, our cohort exclusively comprised individuals with hyperopic anisometropic amblyopia; consequently, these findings may not generalize to myopic subtypes.Future comparative studies between hyperopic and myopic anisometropic amblyopia are warranted.Fourth, although our sample size proved adequate for primary comparisons, it may constrain more detailed subgroup analyses. Fifth, our analysis concentrated on the SCP, exploring the DCP, which plays a crucial role in photoreceptor metabolism, could yield valuable additional insights in future studies with optimized acquisition protocols. Finally, precise documentation of disease duration was unavailable, which precluded analysis of potential stage-dependent effects. Longitudinal studies with extended follow-up periods are needed to determine how the duration of amblyopia influences the evolution of microvascular and structural parameters, particularly whether the observed retinal thickening represents an early-stage phenomenon that may eventually transition to atrophy. Conclusion In this cross-sectional study of children with anisometropic amblyopia, we observed a distinct neurovascular mismatch profile characterized by reduced macular perfusion density, an enlarged FAZ area, increased CMT and RNFL thickness, and delayed visual pathway conduction. Multimodal imaging that combined OCTA and P-VEP revealed significant correlations among these vascular, structural, and functional parameters. RNFL thickness, SCP perfusion density, and axial length emerged as independent predictors of visual acuity in amblyopic eyes, pointing to complex interplays between structure, perfusion, and function. These findings establish a foundation for future longitudinal research to explore whether such parameters could serve as biomarkers for disease monitoring or treatment response. Furthermore, longitudinal, multicenter studies with extended follow-up periods are warranted to validate the generalizability of these findings, assess how disease duration influences the evolution of microvascular and structural parameters, and determine whether the observed structural changes evolve over time. Such investigations will furnish a stronger theoretical foundation and practical framework for clinical ophthalmology. Note Review the key attachments located at the end of the document, ‘Abbreviation List’ and ‘Statement Content’. Acknowledgements None. Abbreviations Optical Coherence Tomography Angiography Visual Evoked Potential Pattern Visual Evoked Potential Superficial Capillary Plexus Deep Capillary Plexus Foveal Avascular Zone Central Macular Thickness Retinal Nerve Fiber Layer Nerve Fiber Layer Best Corrected Visual Acuity Logarithm of the Minimum Angle of Resolution Axial Length International Society for Clinical Electrophysiology of Vision Median First Quartile, Third Quartile Spearman’s Rank Correlation Coefficient Correlation Coefficient P-value Blood Flow Density Vascular Density cAMP Responsive Element-Binding Protein Vascular Endothelial Growth Factor Hypoxia-Inducible Factor 1-alpha Nitric Oxide Endothelin-1 Nuclear Factor Kappa-Light-Chain-Enhancer of Activated B Cells Mitogen-Activated Protein Kinase International Classification of Diseases,11th Revision Hand Motion Light Perception No Light Perception Author contributions A. Concept and Design: Xindan Meng and Yixia Zhang. B: Drafting the article: Xindan Meng and Qing Wang. C: Comprehensive critical revision of the manuscript for pivotal intellectual contributions: Xindan Meng. All the authors approved the final article. Funding None. Data availability The datasets used and/or analysed during the current study are available from the corresponding author on reasonable request. Declarations Ethics approval and consent to participate The study was approved by the Ethics Review Committee of Chongqing Nanping Aier Eye Hospital Group (Approval No: IRB-2022-001) in accordance with the Declaration of Helsinki. Written informed consent was obtained from a legally authorized guardian after explanation of risks and benefits. Consent for publication Not applicable. Copyright statement Agree to grant the BMC Ophthalmology exclusive global rights for the distribution and dissemination of the work through information networks upon its acceptance for publication in the BMC Ophthalmology. Competing interests The authors declare no competing interests. Footnotes Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. References Associated Data Data Availability Statement The datasets used and/or analysed during the current study are available from the corresponding author on reasonable request.